Prostate Cancer - Results from #22500

A prostate-specific antigen doubling time of ostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy - Abstract August 20, 2013

Single-port transvesical laparoscopic radical prostatectomy for organ-confined prostate cancer: Technique and outcomes - Abstract August 19, 2013

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer - Abstract August 19, 2013

The utility of prostate-specific antigen in the management of advanced prostate cancer - Abstract August 19, 2013

Prostate MRI: Who, when, and how? Report from a UK consensus meeting - Abstract August 19, 2013

Four year follow-up of a screening program for prostate cancer in workers - Abstract August 19, 2013

Bone scintigraphy as a new imaging biomarker: The relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases - Abstract August 19, 2013

High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer - Abstract August 19, 2013

A new approach to understanding racial disparities in prostate cancer treatment - Abstract August 19, 2013

The prognostic value of pathologic prostate-specific antigen mass ratio in patients with localized prostate cancer with negative surgical resection margins - Abstract August 19, 2013

A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancer - Abstract August 19, 2013

New radioactive treatment benefits prostate cancer patients August 19, 2013

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy - Abstract August 16, 2013

A method for online verification of adapted fields using an independent dose monitor - Abstract August 16, 2013

Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication - Abstract August 16, 2013

Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population - Abstract August 16, 2013

Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy - Abstract August 16, 2013

Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer - Abstract August 16, 2013

Supraclavicular lymphadenopathy as the initial presentation of metastatic prostate cancer: A case report and review of literature - Abstract August 16, 2013

Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease - Abstract August 16, 2013

Page 1126 of 1436